GlassScriptPhysician profile
Harmoni Gallegos
NPI 1801441365
$1,739.45
in general payments reported to CMS, 2019-2025
20 companies · $652 in 2025
The $652 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $566 · 2024: $522 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735 · Education: $4.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.92 |
| Education | $4.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $309.49 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Lundbeck LLC | $270.39 | 2023-2025 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $136.42 | 2023-2025 | Rexulti |
| Novo Nordisk INC | $131.66 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $129.94 | 2023-2024 | Repatha, Otezla, Evenity |
| Bayer Healthcare Pharmaceuticals INC. | $114.23 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $86.20 | 2023-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Glaxosmithkline, LLC. | $85.90 | 2023-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Sumitomo Pharma America, INC. | $71.19 | 2025 | Gemtesa |
| Lilly USA, LLC | $68.44 | 2025 | Jardiance, Mounjaro, Zepbound |
| Exact Sciences Corporation | $50.32 | 2023-2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $49.56 | 2024-2025 | Voquezna |
| Axsome Therapeutics, INC. | $43.70 | 2025 | Auvelity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.96 | 2023-2024 | Xifaxan |
| Abbvie INC. | $38.13 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $35.72 | 2023 | Nexplanon |
| Pfizer INC. | $24.84 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.11 | 2025 | Caplyta |
| Dexcom, INC. | $15.60 | 2025 | Dexcom G6 Transmitter |
| Electromed, INC. | $13.65 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harmoni Gallegos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.